Clinic template
Hyaluronidase consent form template (UK)
Free hyaluronidase consent form template for UK practitioners, covering allergy risk, patch testing, over-dissolution and dual signature blocks.
Download the document
Free to download. No email needed.
Version 2026-06-03. Adapt it for your clinic before use. Read the full HTML document.
- Audience
- Qualified aesthetic practitioners
- Available now
- Full HTML and a copyable text version, plus PDF and Word downloads
- Scope
- UK practice. Check the requirements where you practise.
- Before use
- Adapt the wording and check it with your insurer.
For qualified practitioners: a template to adapt, not clinical advice.
Use your clinical judgement for every patient. Check the products you use, your protocols, manufacturer instructions, your prescriber's directions where relevant, and your insurer's requirements.
The template
Patient details
Full name: ___________________________
Date of birth: ___________________________
Phone: ___________________________
Email: ___________________________
Address: ___________________________
Treatment details
Reason for dissolving (e.g. migration, overfilling, lumps, unwanted result): ___________________________
Areas to be treated: ___________________________
Original filler product and date, if known: ___________________________
Filler placed at this clinic / elsewhere / unknown (circle): ___________________________
Date of treatment: ___________________________
Prescriber name and registration number: ___________________________
About this treatment
Hyaluronidase is an enzyme used to break down and disperse hyaluronic acid dermal filler. It is a prescription-only medicine, prescribed for you following assessment. Change is often visible within hours and the full effect is judged over the following days. Hyaluronidase works on hyaluronic acid fillers only; it has no effect on other filler types, and product of unknown origin may not respond. More than one session may be required.
Patch test (elective dissolving)
- I have received a test dose of hyaluronidase and have been observed for a reaction in line with this clinic’s protocol, and I understand that a clear patch test reduces but does not eliminate the risk of allergic reaction.
Patch test site and date: ___________________________
Result: ___________________________
Exclusions and screening
- I am not pregnant and not breastfeeding
- I do not have an active skin infection or inflammation at the treatment site
- I have no known allergy to hyaluronidase
- I have disclosed any allergy to bee or wasp venom
- I have disclosed all medication I take and my relevant medical history
Risk acknowledgement
I understand and accept the following recognised risks of hyaluronidase treatment:
- Allergic reaction, including rash, itching, swelling and, rarely, anaphylaxis (a severe, potentially life-threatening reaction requiring emergency treatment)
- Dissolving of my body’s own natural hyaluronic acid in the treated area, which can cause temporary deflation, looseness or accentuated lines while natural hyaluronic acid replenishes
- Bruising, redness, swelling and tenderness at the injection sites
- Infection at the injection site
- Incomplete dissolving, which may require one or more repeat sessions
- An unpredictable final appearance, since the amount, age and type of existing filler cannot always be known, particularly where it was placed elsewhere
- I understand that if I wish to have new filler after dissolving, a settling period will be recommended before re-treatment
Photography
- I consent to clinical photographs being taken before and after treatment for my confidential patient record.
- I additionally consent to my photographs being used for marketing purposes (optional).
Patient declaration
I confirm that I have read and understood the information above, including the risk of allergic reaction, that I have had the opportunity to ask questions and that they have been answered to my satisfaction. The information I have given is true and complete. I consent to hyaluronidase treatment as described.
Patient signature: ___________________________
Print name: ___________________________
Date: ___________________________
Practitioner declaration
I confirm that I have explained this procedure to the patient, including its intended benefits and material risks (including allergic reaction and the possibility of incomplete or over-dissolving), and any available alternatives including not treating, and that the patient has had the opportunity to ask questions. A prescriber has assessed the patient and prescribed this treatment.
Practitioner signature: ___________________________
Print name and qualification: ___________________________
Date: ___________________________
This template is for UK practitioners using hyaluronidase to dissolve hyaluronic acid dermal filler, whether electively (migration, overfilling, lumps, unwanted product) or as part of complication management. Hyaluronidase is a prescription-only medicine, so prescriber involvement is part of the treatment and part of the consent. A defensible form is informed (the allergy risk is acknowledged in writing, not mentioned in passing), specific (the areas and the reason for dissolving are named), signed by patient and practitioner, versioned and retrievable on demand.
Why each section exists
Allergy leads this form because it leads the risk profile: hyaluronidase carries a recognised risk of allergic reaction, rarely including anaphylaxis, which is why elective dissolving conventionally involves a patch test and why the acknowledgement line for it sits in the template rather than in the conversation only. The over-dissolution section exists because the enzyme does not perfectly distinguish filler from the body’s own hyaluronic acid, and a patient who was told in writing that temporary deflation of surrounding tissue is possible is a very different conversation from one who was not.
The incomplete-dissolving acknowledgement protects both sides of a common scenario: older, layered or cross-linked product can need repeat sessions, and unknown product from another clinic may not be hyaluronic acid at all, in which case hyaluronidase will not touch it. The prescriber section reflects the legal position; recording who prescribed and how they assessed the patient is the difference between a compliant POM pathway and a paper exercise. And as with all consent in this specialty, England’s planned licensing scheme points one way: written, versioned, auditable consent as baseline practice.
Using it in practice
Copy the template onto your own letterhead, adapt the patch test wording to the protocol your prescriber has agreed, and date the version; keep superseded versions so you can always produce the wording a patient actually signed. For emergency use in a suspected vascular occlusion, your written emergency protocol governs and consent is handled in line with it; this form is built for the elective pathway. Use it alongside a current medical history form, record the product, batch number, dilution and volumes on a treatment record, and read our hyaluronidase guide for the protocol around the form. The full set of free documents is in the template library.
AesthetiClinic sends this form e-signed to the patient’s phone before the appointment, versions every wording change automatically and files the signed document on the patient record alongside the photographs and batch numbers. See the features overview.
This template is provided as a starting point for UK aesthetics practice. It is not legal or medical advice. Review the wording with your insurer and, where relevant, your prescriber before use.
Before you use it
Adapt it for your clinic.
-
Use your own details.
Name your clinic and the products and services you actually provide. Replace every placeholder before use.
-
Review the wording.
Check the final form against your protocols, your prescriber's directions where relevant, and your insurer's requirements.
-
Keep the version.
Date the final document and keep the exact wording used. Review it when your services, products or terms change.
Send forms to the patient's phone, capture an e-signature and keep the signed record.
See consent forms softwareCopy this template for your clinic.
Copy the full text into your own document and adapt it. Check the final wording with your insurer.
This action copies text.
Optional clinic-owner notes
Subscribe for practical updates. You can read, copy and download available templates without subscribing. Unsubscribe at any time.
Sources and corrections
Something needs correcting? Email hello@aestheticlinic.io. How we check what we publish.
Related practical reading
Send it, sign it, file it.
Free for 14 days. Card required. Charged after 14 days unless cancelled.
Start free trial